<DOC>
	<DOCNO>NCT02289066</DOCNO>
	<brief_summary>This study examine periodontal disease affect complication diabetes treatment periodontal disease affect biomarkers associated complication diabetes .</brief_summary>
	<brief_title>Impact Periodontal Disease Outcomes Diabetes</brief_title>
	<detailed_description>The goal look predictive factor poor oral health impact poor oral health complication diabetes . The prevalence periodontal disease among patient diabetes high general population . Periodontal disease associate dental loss increase systemic inflammation associate cardiovascular bone disease . However , current evidence treatment POD result improvement outcomes patient diabetes mixed . Identifying patterns disease follow biomarkers patient diabetes periodontal disease answer question result appropriate recommendation intervention reduction morbidity , mortality healthcare cost . This study conduct use cross-sectional design . Investigators survey 200 consecutive patient diabetes routine clinic visit use questionnaire . Investigators collect data demographic information , socio-economic status , oral health status/care , diabetes history ( duration , control complication ) bone health . A subgroup 24 participant survey responses suggestive periodontal disease select receive treatment periodontal disease . We measure hemoglobin A1c biomarkers treatment compare level change treatment . Investigators analyze collect data use test proportion , Student 's t-test multivariate regression analysis .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Periodontal Diseases</mesh_term>
	<mesh_term>Gingival Diseases</mesh_term>
	<criteria>All patient 18 year old diabetes 2 year present regular clinic visit eligible inclusion survey part study . Further criteria enrollment subgroup ( n = 24 ) include ; Inclusion criterion Answers questionnaire suggest POD gingivitis . At least 16 teeth place On stable treatment diabetes Hemoglobin A1c 6 10 Treatment antiinflammatory medication Cigarette smoke Treatment thiazolidinediones Previous diagnosis osteoporosis treatment osteoporosis FDA approve agent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>